Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

AI Timing in Chest X-ray Interpretation Using Eye-Tracking (CREAITED)

2 de julho de 2026 atualizado por: University Hospitals, Leicester

A Within-Subject Eye-Tracking Study Examining How the Timing of AI Decision Support Influences Visual Search Behaviour, Diagnostic Accuracy, and Trust During Chest X-ray Interpretation

Chest X-rays are commonly used to help diagnose and manage chest conditions. Artificial intelligence (AI) tools are increasingly being used to support chest X-ray interpretation. However, it is not yet clear whether the timing of AI information affects how clinicians review images, make decisions, and use AI support.

This study will look at whether showing AI information before or after a clinician first reviews a chest X-ray changes how they look at the image, how long they take, their interpretation decisions, their confidence, and their trust in AI support.

Healthcare professional participants will complete two chest X-ray interpretation sessions in a controlled NHS research setting. During each session, participants will review de-identified chest X-ray images while wearing eye-tracking equipment. Eye-tracking will record where a participant looks on the image and how long they spend looking at different areas.

In one session, AI information will be shown before the participant reviews the chest X-ray. In the other session, AI information will be shown after the participant has first reviewed the chest X-ray. The order of these two sessions will be balanced across participants.

The study uses de-identified chest X-ray images from existing examinations. It does not involve patients directly, does not change clinical care, and no clinical decisions will be made from the study readings. Participants will also complete a short questionnaire about their experience of using AI support. A separate anonymous survey will collect wider views from clinicians, patients, members of the public, and healthcare staff about the use of AI in chest X-ray interpretation.

Visão geral do estudo

Descrição detalhada

CREAITED is a behavioural diagnostic reader study examining how the timing of artificial intelligence (AI) decision-support information influences chest X-ray interpretation by healthcare professionals. The study focuses on whether showing AI information before or after a participant first reviews a chest X-ray affects visual search behaviour, interpretation time, clinical decision-making, confidence, and trust in AI support.

Chest X-rays are widely used in clinical practice, but interpretation can be challenging because findings may be subtle and normal anatomy can overlap with abnormalities. AI systems are increasingly used to support image interpretation by highlighting suspected abnormalities. However, less is known about how clinicians use AI information during reporting tasks, including whether seeing AI output early changes attention, reliance, confidence, or interpretation strategy. Current clinical guidance generally supports independent image review before consulting decision-support tools, but direct evidence on AI timing in chest X-ray interpretation remains limited. This study is designed to provide controlled evidence on that question.

The main reader study is a single-site study at University Hospitals of Leicester NHS Trust. It uses a within-subject, counterbalanced, multi-reader, multi-case design. The exposure of interest is the timing of AI decision-support presentation during chest X-ray interpretation. The AI information is used only within the research task and is not used to guide real patient care.

Healthcare professional participants will complete two chest X-ray interpretation sessions in a controlled NHS research setting. Participants will include clinicians and healthcare professionals who interpret, review, check, or act on chest X-ray findings as part of their current or recent professional role. The study is not designed to assess individual competence. Individual participant results will not be used for employment, appraisal, training progression, formal assessment, or performance management.

Each participant will complete both AI timing conditions. In one session, AI information will be shown before the participant reviews the chest X-ray. In the other session, the participant will first review the chest X-ray without AI information, and AI information will then be shown afterwards. The order of these two-timing conditions will be balanced across participants using a pre-generated allocation schedule. The two sessions will be separated by at least four weeks to reduce recall and learning effects.

Each case will use a two-phase interpretation process. In the first phase, only one information source is shown, either the original chest X-ray or the AI output, depending on the timing condition. In the second phase, the alternative information source is introduced so that both the chest X-ray and AI information can be viewed. Participants complete a structured interpretation response after the first phase and may review or revise their response after seeing both information sources before submitting their final response for that case.

During each session, participants will review de-identified chest X-ray images using a dedicated diagnostic reporting workstation in a controlled reporting environment. The reader study is designed for approximately 20 complete participant datasets. Each participant will review 25 study chest X-ray cases per session across two sessions. The same study image set will be used across both sessions, with case order independently randomised for each session. Warm-up cases from a separate image pool will be used at the start of each session to familiarise participants with the task and equipment, and these warm-up cases will not be included in the main analysis.

The image set will include a mix of normal and abnormal chest X-rays and a range of diagnostic difficulty. Cases will be selected from routine clinical imaging and de-identified before use in the study. Ground truth labels and image areas of interest will be defined through a structured clinical review process. These reference data will support analysis of participant interpretation, localisation, and visual search behaviour.

Participants will wear lightweight eye-tracking equipment during the interpretation task. Eye-tracking will record where participants look on the image and how long they spend looking at different areas. These data will be used to assess visual search behaviour, including how attention is distributed across image areas, how participants view areas highlighted by the AI, and whether visual search differs between the AI-first and chest X-ray-first timing conditions.

Study sessions will be self-paced, with optional breaks to reduce fatigue. A researcher will be present to monitor equipment and provide technical support if needed, while minimising interaction that could influence participant behaviour. After completing the reader study sessions, participants will complete a short questionnaire about confidence, trust, perceived usefulness, workflow impact, and the influence of AI timing. Participants will also be debriefed about the study design and the reason for comparing different AI timing conditions.

The study will collect de-identified imaging data, eye-tracking data, structured reporting responses, timing data, localisation information, and questionnaire responses. The primary outcome is case interpretation time, measured for each chest X-ray case. Other outcomes include diagnostic performance, clinical interpretation or management responses, confidence in decision-making, participant perceptions of AI support, and eye-tracking measures of visual search behaviour.

The reader study uses de-identified chest X-ray images from existing examinations. No patients are recruited directly into the reader study, no clinical care is changed, and no clinical decisions will be made from participant study readings. The study does not involve investigational medicinal products, and no biological samples are collected.

Patient and public involvement informed the development of the study. Input from patients, members of the public, healthcare staff, and other stakeholders helped refine the focus on trust, confidence, transparency, human oversight, communication preferences, and the timing of AI information. This input also informed participant-facing materials and the topic areas included in the supplementary survey.

Alongside the main reader study, a separate anonymous supplementary survey will collect wider views about AI use in chest X-ray interpretation. This survey will be administered remotely and will be open to relevant groups, including clinicians, patients, members of the public, and healthcare staff. It will explore views on trust, safety, responsibility, communication, acceptability, governance, and expectations of AI-supported chest X-ray interpretation. The supplementary survey is independent of the reader study sessions and does not influence the image interpretation task.

Study data will be handled using study identifiers and secure NHS systems. Results will be reported in aggregate form so that individual participants are not identified. The findings are intended to help inform safer and more effective use of AI decision support in chest X-ray interpretation.

Tipo de estudo

Intervencional

Inscrição (Estimado)

24

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Leicestershire
      • Leicester, Leicestershire, Reino Unido, LE1 5WW
        • Recrutamento
        • University Hospitals of Leicester NHS Trust
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

Main reader study:

  • Healthcare professionals aged 18 years or over
  • Registered to practise in the UK
  • Employed by the NHS or another healthcare service operating in the UK
  • Current or recent, within the last 3 years, clinical experience involving chest X-ray interpretation, review, or use in clinical practice
  • Able to attend two onsite study sessions at University Hospitals of Leicester NHS Trust at mutually agreed times
  • Able and willing to provide written informed consent
  • Compatible with the eye-tracking equipment

Supplementary survey:

  • Adults aged 18 years or over
  • Live in the UK or have used the NHS or another UK healthcare service within the last 5 years
  • Able to provide informed electronic consent
  • Belong to one of the following respondent groups: healthcare professionals or healthcare staff, patients or carers, or members of the public
  • Healthcare professional respondents may include adults involved in requesting, interpreting, checking, or acting on chest X-ray findings in clinical practice

Exclusion Criteria:

Main reader study:

  • Inability to attend both onsite study sessions at University Hospitals of Leicester NHS Trust
  • Eye-tracking incompatibility, such as visual, neurological, or physical conditions preventing adequate gaze tracking or participant comfort
  • Direct involvement in selection, adjudication, or preparation of the chest X-rays used in the study
  • Conflicts of interest, including direct involvement in development of the AI system under evaluation
  • Prior participation in a closely related AI chest X-ray study where overlap in image sets or study procedures may compromise validity, assessed on a case-by-case basis

Supplementary survey:

  • Aged under 18 years
  • Does not live in the UK and has not used the NHS or another UK healthcare service within the last 5 years
  • Unable to provide informed electronic consent
  • Does not meet one of the eligible respondent groups for the survey

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Diagnóstico
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Original CXR First Sequence
Participants complete the original chest X-ray first timing condition in Session 1, followed by the AI output first timing condition in Session 2. Sessions are separated by at least four weeks.
Participants first review the original chest X-ray without AI output and complete an initial structured interpretation response. AI output is then introduced, and participants may review or revise their response before submitting the final response for that case.
Participants first view AI output before reviewing the original chest X-ray. The original chest X-ray is then introduced, and participants complete or revise their structured interpretation response before submitting the final response for that case.
Experimental: AI Output First Sequence
Participants complete the AI output first timing condition in Session 1, followed by the original chest X-ray first timing condition in Session 2. Sessions are separated by at least four weeks.
Participants first review the original chest X-ray without AI output and complete an initial structured interpretation response. AI output is then introduced, and participants may review or revise their response before submitting the final response for that case.
Participants first view AI output before reviewing the original chest X-ray. The original chest X-ray is then introduced, and participants complete or revise their structured interpretation response before submitting the final response for that case.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Chest X-ray Case Interpretation Time
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Case interpretation time is the duration, in seconds, from initial case display to final structured report submission. Change in case interpretation time will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Change in Chest X-ray Case Diagnostic Accuracy
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Diagnostic accuracy will be assessed using structured report outcomes compared with clinician-verified chest X-ray ground truth. Each participant's final structured interpretation for each chest X-ray case will be compared with the verified study ground truth for that case. Change in diagnostic accuracy will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Change in Chest X-ray Case Visual Search Behaviour
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Visual search behaviour will be assessed using predefined eye-tracking metrics that capture gaze location and search behaviour during chest X-ray interpretation. Metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion. Change in visual search behaviour will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Trust in AI Support After Reader-Study Completion
Prazo: Immediately after Session 2, anticipated average 5 weeks after enrolment
Trust in AI support will be assessed using structured questionnaire ratings after participants have completed both Session 1 and Session 2. This measure captures participants' overall perceived usefulness, reliance on AI support, and willingness to revise decisions after reviewing AI information.
Immediately after Session 2, anticipated average 5 weeks after enrolment

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Chest X-ray Case Clinical Management Recommendations
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Clinical management recommendations will be recorded from participants' structured report responses for each chest X-ray case. Change in clinical management recommendations will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Change in Chet X-ray Case Decision Confidence
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Decision confidence will be recorded as the participant's confidence rating in their final diagnostic judgement for each chest X-ray case. Change in decision confidence will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Overall Reflective Confidence After Reader-Study Completion
Prazo: Immediately after Session 2, anticipated average 5 weeks after enrolment
Overall reflective confidence will be assessed using structured questionnaire ratings after participants completed both Session 1 and Session 2. This measure captures participants' overall perceived confidence in their interpretive decisions across the reader study.
Immediately after Session 2, anticipated average 5 weeks after enrolment
Participant Perceptions of AI Support After Reader-Study Completion
Prazo: Immediately after Session 2, anticipated average 5 weeks after enrolment
Participant perceptions of AI support will be assessed using a post-study questionnaire after participants completed both Session 1 and Session 2. This measure captures participants' overall perceptions of usability, clarity, workflow implications, communication preferences, and responsibility.
Immediately after Session 2, anticipated average 5 weeks after enrolment
Broader Attitudes Toward AI in Chest X-ray Interpretation
Prazo: 2 months
Broader attitudes toward AI in chest X-ray interpretation will be assessed using a separate anonymous online supplementary survey. The survey will collect views on trust, responsibility, communication preferences, acceptability, and related perceptions from patients, members of the public, healthcare professionals, and healthcare staff.
2 months

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Differences in Chest X-ray Case Diagnostic Accuracy, Visual Search Behaviour, and Trust in AI Support by Clinical Background and Experience
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Subgroup differences between participants with different clinical background and years of experience. Differences between participant subgroups will be measured for diagnostic accuracy, visual search behaviour, and trust in AI support, obtained during Session 1 and Session 2. Diagnostic accuracy uses structured report outcomes. Visual search behaviour metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion. Trust in AI support uses structured questionnaire ratings.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Association Between Chest X-ray Case Visual Search Behaviour and Diagnostic Accuracy
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
The association between visual search behaviour and diagnostic accuracy will be explored using outputs obtained during Session 1 and Session 2. Diagnostic accuracy will be assessed using structured report outcomes. Visual search behaviour metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Association Between Chest X-ray Case Visual Search Behaviour and Case Complexity
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
The association between visual search behaviour and chest X-ray case complexity will be explored using outputs obtained during Session 1 and Session 2. Visual search behaviour metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion. Chest X-ray case complexity is predefined as low, moderate, or high.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Association Between Chest X-ray Case Visual Search Behaviour and AI Error Type
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
The association between visual search behaviour and chest X-ray case AI error type will be explored using outputs obtained during Session 1 and Session 2. Visual search behaviour metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion. Chest X-ray case AI error type is predefined as false-positive or false-negative.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Visual Engagement with AI Output Interface Areas of Interest
Prazo: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks
Visual engagement with AI output interface elements will be assessed using predefined areas of interest drawn over the AI confidence indicator and other displayed AI interface features. Eye-tracking metrics will include time to first fixation, dwell time, fixation count, mean fixation duration, revisit count, and fixation dispersion within these areas of interest. Differences in these metrics will be assessed using data obtained during Session 1 and Session 2.
Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

30 de junho de 2026

Conclusão Primária (Estimado)

1 de dezembro de 2026

Conclusão do estudo (Estimado)

1 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

10 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

29 de junho de 2026

Primeira postagem (Real)

30 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de julho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

2 de julho de 2026

Última verificação

1 de julho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 204269
  • 347920 (Outro identificador: IRAS Project ID)
  • 26/EE/0111 (Outro identificador: REC reference)

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever